Ignite Creation Date:
2024-05-06 @ 7:09 AM
Last Modification Date:
2024-10-26 @ 11:45 AM
Study NCT ID:
NCT02474290
Status:
COMPLETED
Last Update Posted:
2019-08-26
First Post:
2015-06-14
Brief Title:
Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML
Sponsor:
Nanfang Hospital Southern Medical University
Organization:
Nanfang Hospital Southern Medical University
Organization Data
Organization:
Nanfang Hospital Southern Medical University
Class:
OTHER
Study ID:
Sorafenib-Flt3 AML-2015
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nanfang Hospital Southern Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
Qifa Liu
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Nanfang Hospital Southern Medical University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| The First Affiliated Hospital of Guangzhou Medical University | OTHER |
| Peking University Peoples Hospital | OTHER |
| Third Affiliated Hospital Sun Yat-Sen University | OTHER |
| Zhujiang Hospital | OTHER |
| Xiangya Hospital of Central South University | OTHER |
| First Peoples Hospital of Chenzhou | OTHER |